(), Ulf-G. Gerdtham
(), Tobias Rydén
, Pia Munkholm
, Selwyn Odes
, Bjørn Moum
, Reinhold Stockbrügger
and Stefan Lindgren
Sixten Borg: Health Economics Unit, Lund University, Postal: Health Economics Unit, Lund University, Medicon Village, SE-22381 Lund, Sweden
Ulf-G. Gerdtham: Department of Economics, Lund University, Postal: Department of Economics, School of Economics and Management, Lund University, Box 7082, S-220 07 Lund, Sweden
Tobias Rydén: Department of Information Technology, Uppsala University, Postal: Department of Information Technology, Uppsala University, Sweden
Pia Munkholm: Department of Gastroenterology, North Zealand University Hospital, Postal: Department of Gastroenterology, Medical Section, Capital Region of Copenhagen, North Zealand University Hospital, Denmark
Selwyn Odes: Faculty of Health Sciences, Ben-Gurion University of the Negev, Postal: Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
Bjørn Moum: University of Oslo, Institute of Clinical Medicine, Postal: University of Oslo, Institute of Clinical Medicine, Oslo, Norway
Reinhold Stockbrügger: Department of Gastroenterology and Hepatology, University Hospital Maastricht, Postal: Department of Gastroenterology and Hepatology, University Hospital Maastricht, Maastricht, Netherlands
Stefan Lindgren: Department of Clinical Sciences Malmö, Lund University, Postal: Department of Clinical Sciences Malmö, Lund University
Abstract: Heterogeneity in patient populations is an important issue in health economic evaluations, as the cost-effectiveness of an intervention can vary between patient subgroups, and an intervention which is not cost-effective in the overall population may be cost-effective in particular subgroups. Identifying such subgroups is of interest in the allocation of healthcare resources. Our aim was to develop a method for cost-effectiveness analysis in heterogeneous chronic diseases, by identifying subgroups (phenotypes) directly relevant to the cost-effectiveness of an intervention, and by enabling cost-effectiveness analyses of the intervention in each of these phenotypes. We identified phenotypes based on healthcare resource utilization, using finite mixtures of underlying disease activity models: first, an explicit disease activity model, and secondly, a model of aggregated disease activity. They differed with regards to time-dependence, level of detail, and what interventions they could evaluate. We used them for cost-effectiveness analyses of two hypothetical interventions. Allowing for different phenotypes improved model fit, and was a key step towards dealing with heterogeneity. The cost-effectiveness of the interventions varied substantially between phenotypes. Using underlying disease activity models for identifying phenotypes as well as cost-effectiveness analysis appears both feasible and useful in that they guide the decision to introduce an intervention.
25 pages, February 6, 2015
Full text files
Questions (including download problems) about the papers in this series should be directed to David Edgerton ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2020-02-16 18:56:48.